Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
Portfolio Pulse from Maureen Meehan
Ovax Inc. has secured $10 million in funding to develop a groundbreaking fentanyl vaccine aimed at preventing fatal overdoses. The startup, founded by JR Rahn, who previously founded Mind Medicine Inc. (NASDAQ:MNMD), plans to begin human trials early next year. The vaccine aims to neutralize fentanyl's effects before they manifest, unlike naloxone which reverses overdoses after they occur.
June 26, 2024 | 10:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mind Medicine Inc. (NASDAQ:MNMD) is indirectly mentioned as the previous venture of Ovax Inc.'s co-founder JR Rahn. This connection may bring some attention to MNMD due to Rahn's new high-profile project.
JR Rahn's involvement in Ovax Inc. and his previous success with Mind Medicine Inc. could draw investor interest to MNMD, potentially boosting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 30